Andromeda Biotech Announces The Acceptance Of Two Manuscripts For Publication Describing Its Phase 3 DIA-AID 1 Study
1/13/2014 9:59:23 AM
YAVNE, Israel, Jan. 12, 2014 (GLOBE NEWSWIRE) -- Andromeda Biotech Ltd. announces that two peer-reviewed articles were accepted for publication in Diabetes Care. The publications, which discuss clinical results from the phase 3 DIA-AID 1 study, will appear in the March issue accompanied by an Editorial.
Help employers find you! Check out all the jobs and post your resume.